MEDANTA (Global Health) Share Price Target For Tomorrow, Next Week & Next Month
Global Health Limited | |||
 | Price: ₹1,408.40 (-0.87%) | ||
| 52 Week Low: ₹935.50 52 Week High: ₹1,456.50 | |||
| Market Capital: 28,786.89 Crore (Largecap) | |||
| Healthcare -> Medical Care Facilities | |||
MEDANTA (Global Health) Stock Comparison: MEDANTA (Global Health) vs Narayana Hrudayalaya | MEDANTA (Global Health) vs Krishna Institute of Medical Sciences | MEDANTA (Global Health) vs Aster Healthcare | MEDANTA (Global Health) vs Gland Pharma | MEDANTA (Global Health) vs Syngene International | MEDANTA (Global Health) vs J.B. Chemicals & Pharma | |||
Show Table of Contents
MEDANTA (Global Health) Recent Performance
Over the past 451 trading days, the value of MEDANTA (Global Health)'s stock has gained ₹577.60 (+69.52%). On 07 Nov 2023, one share was worth ₹830.80 and by 05 Sep 2025, the value jumped to ₹1408.40. During this period it created a highest high of ₹1513.90 and lowest low of ₹816.00.
MEDANTA (Global Health) Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 1542 (+9.48%) | Fibonacci Extension Level 123.60% |
| Tomorrow Target 2 | 1511 (+7.28%) | Price Action: Apr 2024 High |
| Tomorrow Target 1 | 1490 (+5.79%) | Price Action: May 2024 High |
| Current Price | 1408.40 | MEDANTA (Global Health)'s share price as of 05 Sep 2025 |
| Stop Loss 1 | 1359 (-3.51%) | Price Action: 21 Aug 2025 Low |
| Stop Loss 2 | 1345 (-4.51%) | Price Action: 04 Aug 2025 High |
| Stop Loss 3 | 1330.5 (-5.54%) | Price Action: 31 Jul 2025 High |
Summary
05 Sep 2025: MEDANTA (Global Health) finished the day at ₹1408.40, losing ₹-12.40 (-0.87%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -5.53% to 9.49% with:
- Target prices: ₹1490 to ₹1542
- Support levels: ₹1359 to ₹1330.5
- Recent high: ₹1437.90
- Recent low: ₹1398.00
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
MEDANTA (Global Health) Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 1465.97 (+4.08%) | Fibonacci Extension Level 64.90% |
| Next Week Target 2 | 1448.8 (+2.86%) | Price Action: Mar 2024 High |
| Next Week Target 1 | 1428.9 (+1.45%) | Price Action: 20 Aug 2025 High |
| Current Price | 1408.40 | MEDANTA (Global Health)'s share price as of 05 Sep 2025 |
| Stop Loss 1 | 1400 (-0.6%) | Price Action: 21 Aug 2025 High |
| Stop Loss 2 | 1385.7 (-1.62%) | Price Action: 28 Aug 2025 Low |
| Stop Loss 3 | 1368.1 (-2.87%) | Price Action: Sep 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.86% to 4.09% with:
- Upper targets: ₹1428.9 to ₹1465.97
- Support levels: ₹1400 to ₹1368.1
MEDANTA (Global Health) Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 1542 (+9.48%) | Fibonacci Extension Level 123.60% |
| Next Month Target 2 | 1511 (+7.28%) | Price Action: Apr 2024 High |
| Next Month Target 1 | 1490 (+5.79%) | Price Action: May 2024 High |
| Current Price | 1408.40 | MEDANTA (Global Health)'s share price as of 05 Sep 2025 |
| Stop Loss 1 | 1388.95 (-1.39%) | Price Action: Jun 2024 High |
| Stop Loss 2 | 1373.5 (-2.48%) | Price Action: 22 Aug 2025 Low |
| Stop Loss 3 | 1359 (-3.51%) | Price Action: 21 Aug 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.51% to 9.49% with:
- Target range: ₹1490 to ₹1542
- Support levels: ₹1388.95 to ₹1359
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
